SCHEMBL29525119

SCHEMBL29525119

O=C(CCCC/C=C(\COc1cccc2ccccc12)C(=O)NCCCN1CCCC1=O)NO

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ ATM Q13315 1/20 0.44
▸ HPGD P15428 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CREBBP Q92793 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ TSHR P16473 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.40
▸ USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305790 1.00 KDM4E (0.48) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1305792 1.00 KDM4E (0.48) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1306318 0.92 KDM4E (0.47) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1306323 0.92 KDM4E (0.47) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1305962 0.91 L3MBTL1 (0.48) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1305961 0.91 L3MBTL1 (0.48) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1307540 0.87 KDM4E (0.45) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL1307537 0.87 KDM4E (0.45) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL29488470 0.86 KDM4E (0.35) KDM4EALDH1A1HSD17B10L3MBTL1NPC1
SCHEMBL17043090 0.85 P2RX3 (0.44) KDM4EALDH1A1HSD17B10L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-112930177-B Pharmaceutical compositions containing alkylcarbamoyl naphthoyl octenoyl hydroxyamide phosphate, tartrate or combinations thereof and methods of making the same 晶体基因技术株式会社 2024-01-30 — — CN disclosed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
Send feedback